Beta test rollout. This site is in community QA — please send feature requests, bug reports and data corrections on the Feedback page or on GitHub.

Home
    Disclaimer
    Phenylpiracetam molecular structure

    Phenylpiracetam Stats & Data

    Carphedon Phenotropil Fonturacetam
    NPS DataHub
    MW218.26
    FormulaC12H14N2O2
    CAS77472-70-9
    IUPAC2-(2-oxo-4-phenylpyrrolidin-1-yl)acetamide
    SMILESNC(=O)CN1CC(CC1=O)c1ccccc1
    InChIKeyLYONXVJRBWWGQO-UHFFFAOYSA-N
    Phenethylamines Others
    Chemical Class Racetam
    Psychoactive Class Stimulant

    Receptor Profile

    Receptor Actions

    Inhibitors
    Dopamine reuptake inhibitor (selective, atypical)
    Norepinephrine reuptake inhibitor (R-enantiomer)
    Modulators
    AMPA receptor positive allosteric modulator
    Other
    Nicotinic acetylcholine receptor (α4β2) ligand
    Acetylcholine synthesis enhancer

    Toxicity

    PsychonautWiki

    Several studies suggest that this substance is safe even when high doses are consumed for a long period of time although it is worth noting that the exact toxic dosage is unknown. Anecdotal evidence from those within the community who have tried phenylpiracetam suggest that there do not seem to be any negative health effects attributed to simply trying this drug at low to moderate doses by itself and using it sparingly (but nothing can be completely guaranteed). It is strongly recommended that one use harm reduction practices when using this drug.

    Effect Profile

    Curated + 9 Reports
    Stimulant 6.8

    Strong focus and stimulation with low euphoria and anxiety/jitters

    Stimulation / Energy×3
    8
    Euphoria / Mood Lift×2
    2
    Focus / Productivity×2
    9
    Anxiety / Jitters×1
    2

    Tolerance & Pharmacokinetics

    drugs.wiki

    Tolerance Decay

    Full tolerance 1h Half tolerance 10d Baseline ~14d

    Experience Report Analysis

    Erowid
    14 Reports
    9 Single-substance
    2008–2023 Date Range
    12 With Age Data
    6 Effects Detected

    Demographics

    Gender Distribution

    Too few reports for a chart: gender is known from 14 reports, and a split is drawn only from 20 reports or more. Counts are shown instead. Why 20?

    • Male 12 of 14
    • Not Specified 2 of 14

    Age Distribution

    Reports Over Time

    Effect Analysis

    Erowid

    Effects aggregated from 9 experience reports (9 single-substance Erowid)

    9 Reports
    6 Effects Detected
    3 Positive
    2 Adverse
    1 Neutral

    Effect Sentiment Distribution

    Confidence Distribution

    Each bar is the share of reports mentioning the effect; its whisker, and the band on the rows below, is the 95% interval: where the share could plausibly be with other reports of the same kind.

    Too few reports for bars: these effects come from 9 single-substance Erowid reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?

    Positive Effects 3

    Stimulation 7 of 9 70%
    Focus Enhancement 6 of 9 70%
    Music Enhancement 3 of 9 70%

    Adverse Effects 2

    Increased Heart Rate 4 of 9 70%
    Anxiety 3 of 9 70%
    Show 1 neutral or unclassified mention
    Sedation 3 of 9

    Dosage Distribution

    Dose distribution from experience reports, one dose per report (the first listed). Doses above Q3 + 3×IQR, far above what people typically take, are left out of the median and range and listed under each route: most are real heavy doses or overdoses, not mistakes.

    Median: 250.0 mg IQR: 105.0–300.0 mg n=10

    Real-World Dose Distribution

    Erowid

    From 20 of 24 recorded dose entries: those that state a weight (mg, g or µg), in routes with at least five of them. Values above Q3 + 3×IQR, far above what people typically take, are left out; they can include real heavy doses and overdoses, not only mistakes.

    Oral (n=19)

    Median: 200.0mg 25th: 100.0mg 75th: 300.0mg 90th: 320.0mg

    Common Combinations

    Most co-occurring substances, as a share of all 14 reports filed under Phenylpiracetam

    Too few reports for bars: these combinations come from 14 reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?

    • Alcohol 3 of 14

    Form / Preparation

    Most common forms and preparations, as a share of the 8 reports that give one

    Too few reports for bars: these forms come from 8 reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?

    • Powder / Crystals 5 of 8
    • Pill / Tablet 2 of 8

    Body-Weight Dosing

    Dose per kg of body weight, one dose per report (the first listed), from reports giving a weight of 30–250 kg. Doses above Q3 + 3×IQR, far above what people typically take, are left out of the median and range and listed under each route.

    Median: 2.305 mg/kg IQR: 1.488–3.835 mg/kg n=10

    Redose Patterns

    Redosing behavior across 12 reports

    6 of 12 Redosed
    1.5 Avg Doses

    Too few reports for a chart: redosing is known from 12 reports, and a split is drawn only from 20 reports or more. Counts are shown instead. Why 20?

    • Single dose 6 of 12
    • Redosed 6 of 12
    ← Back to Phenylpiracetam